Clinical trial

Effects of HMG-coA Reductase Inhibitor on Rheumatoid Arthritis

NCT00555230

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-07-01

PhasePHASE2

Study timeline

Study start (unknown)2007-07-01Date precision: month

Registry last updated2011-01-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

RosuvastatinDRUG · verified · RxNorm: rosuvastatin

PlaceboDRUG

Sponsors & collaborators

Chinese University of Hong Konglead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00555230 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.